Annual D&A:
$18.00K-$11.00K(-37.93%)Summary
- As of today, AKRO annual D&A is $18.00 thousand, with the most recent change of -$11.00 thousand (-37.93%) on December 31, 2024.
- During the last 3 years, AKRO annual D&A has fallen by -$226.00 thousand (-92.62%).
- AKRO annual D&A is now -93.08% below its all-time high of $260.00 thousand, reached on December 31, 2022.
Performance
AKRO Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$0.00$0.00(0.00%)Summary
- As of today, AKRO quarterly D&A is $0.00, unchanged on June 30, 2025.
- Over the past year, AKRO quarterly D&A has dropped by -$1000.00 (-100.00%).
- AKRO quarterly D&A is now -100.00% below its all-time high of $69.00 thousand, reached on June 30, 2023.
Performance
AKRO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$16.00K-$1000.00(-5.88%)Summary
- As of today, AKRO TTM D&A is $16.00 thousand, with the most recent change of -$1000.00 (-5.88%) on June 30, 2025.
- Over the past year, AKRO TTM D&A has increased by +$122.00 thousand (+115.09%).
- AKRO TTM D&A is now -94.03% below its all-time high of $268.00 thousand, reached on June 30, 2023.
Performance
AKRO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AKRO Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -37.9% | -100.0% | +115.1% |
| 3Y3 Years | -92.6% | -100.0% | -93.7% |
| 5Y5 Years | +100.0% | -100.0% | -89.5% |
AKRO Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -93.1% | at low | -100.0% | +100.0% | -94.0% | +115.1% |
| 5Y | 5-Year | -93.1% | >+9999.0% | -100.0% | +100.0% | -94.0% | +115.1% |
| All-Time | All-Time | -93.1% | >+9999.0% | -100.0% | +100.0% | -94.0% | +115.1% |
AKRO Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(0.0%) | $16.00K(-5.9%) |
| Mar 2025 | - | $0.00(-100.0%) | $17.00K(-5.6%) |
| Dec 2024 | $18.00K(-37.9%) | $15.00K(+1400.0%) | $18.00K(+260.0%) |
| Sep 2024 | - | $1000.00(0.0%) | $5000.00(+104.7%) |
| Jun 2024 | - | $1000.00(0.0%) | -$106.00K(-178.9%) |
| Mar 2024 | - | $1000.00(-50.0%) | -$38.00K(-231.0%) |
| Dec 2023 | $29.00K(-88.8%) | $2000.00(+101.8%) | $29.00K(-68.5%) |
| Sep 2023 | - | -$110.00K(-259.4%) | $92.00K(-65.7%) |
| Jun 2023 | - | $69.00K(+1.5%) | $268.00K(+1.5%) |
| Mar 2023 | - | $68.00K(+4.6%) | $264.00K(+1.5%) |
| Dec 2022 | $260.00K | $65.00K(-1.5%) | $260.00K(+0.8%) |
| Sep 2022 | - | $66.00K(+1.5%) | $258.00K(+2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $65.00K(+1.6%) | $252.00K(+2.0%) |
| Mar 2022 | - | $64.00K(+1.6%) | $247.00K(+1.2%) |
| Dec 2021 | $244.00K(+14.6%) | $63.00K(+5.0%) | $244.00K(+1.2%) |
| Sep 2021 | - | $60.00K(0.0%) | $241.00K(+6.2%) |
| Jun 2021 | - | $60.00K(-1.6%) | $227.00K(+3.2%) |
| Mar 2021 | - | $61.00K(+1.7%) | $220.00K(+3.3%) |
| Dec 2020 | $213.00K(>+9900.0%) | $60.00K(+30.4%) | $213.00K(+39.2%) |
| Sep 2020 | - | $46.00K(-13.2%) | $153.00K(+43.0%) |
| Jun 2020 | - | $53.00K(-1.9%) | $107.00K(+98.1%) |
| Mar 2020 | - | $54.00K(>+9900.0%) | $54.00K(>+9900.0%) |
| Dec 2019 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2019 | - | $0.00 | $0.00 |
FAQ
- What is Akero Therapeutics, Inc. annual D&A?
- What is the all-time high annual D&A for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. annual D&A year-on-year change?
- What is Akero Therapeutics, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Akero Therapeutics, Inc. TTM D&A?
- What is the all-time high TTM D&A for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. TTM D&A year-on-year change?
What is Akero Therapeutics, Inc. annual D&A?
The current annual D&A of AKRO is $18.00K
What is the all-time high annual D&A for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high annual D&A is $260.00K
What is Akero Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, AKRO annual D&A has changed by -$11.00K (-37.93%)
What is Akero Therapeutics, Inc. quarterly D&A?
The current quarterly D&A of AKRO is $0.00
What is the all-time high quarterly D&A for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high quarterly D&A is $69.00K
What is Akero Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, AKRO quarterly D&A has changed by -$1000.00 (-100.00%)
What is Akero Therapeutics, Inc. TTM D&A?
The current TTM D&A of AKRO is $16.00K
What is the all-time high TTM D&A for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high TTM D&A is $268.00K
What is Akero Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, AKRO TTM D&A has changed by +$122.00K (+115.09%)